target menu
 

Delwel, Ruud

Back to List

 

Ruud Delwel received his PhD at the Erasmus Medical Center in Rotterdam, where he studied growth and differentiation of acute myeloid leukemias (AML). He did his postdoctoral training at the St. Jude's Childrens Research Hospital in Memphis, Tennessee. By means of retroviral insertional mutagenesis, he identified a novel leukemia disease gene and demonstrated its involment a differentiation arrest, a hallmark for myeloid leukemia.

He started his own research group at the Department of Hematology at the Erasmus MC in 1992. Using the retrovirus approach he identified a large number of novel transforming genes in mouse leukemias. Moreover, by using state-of-the art molecular approaches he demonstrated the clinical relevance for several of these genes by analysing large AML patient cohorts. In 1999, he became Associate Professor and in 2010 Professor “Molecular Leukemogenesis” at the Hematology department. He runs a research group of several postdoctoral fellows and graduate students. He is one of the Course Directors of the MSc Molecular Medicine program at Erasmus MC. 


Peter J.M. Valk, Roel G.W. Verhaak, M. Antoinette Beijen, Claudia A.J. Erpelinck, Sahar Barjesteh van Waalwijk van Doorn - Khosrovani, Judith M. Boer, H. Berna Beverloo, Michael J. Moorhouse, Peter J. van der Spek, Bob Löwenberg, Ruud Delwel (2004)
Prognostically Useful Gene Expression Profiles in Acute Myeloid Leukemia
N Engl J Med 350(16):1617-28

Sanne Lugthart, Antoinette van Hooven-Bijen, Bob lowenberg, Peter Valk and Ruud Delwel (2008)
High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated
Blood 111:4329-4337

Bas J. Wouters, Bob Lowenberg, Claudia A.J. Erpelinck-Verschueren, Wim L.J. van Putten, Peter J.M. Valk, and Ruud Delwel (2009)
Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome
Blood 113:3088-3091

Maria Figueroa, Bas Wouters, Lucy Skrabanek. Jacob Glass, Yushan Li, Claudia Erpelinck, Ton Langerak, B Lowenberg, M Fazzari, JM Greally, P Valk.  Ari Melnick and Ruud Delwel (2009)
Integrated epigenetic analyses delineates a biologically distinct form of acute myeloid leukemia with T-cell lineage infidelity
Blood 113:2795-2804 

Maria E. Figueroa, Sanne Lugthart, Yushan Li, Claudia Erpelinck-Verschueren, Xutao Deng, Paul J. Christos, Elizabeth Schifano, Jim Booth, Lucy Skrabanek, Fabien Campagne, Madhu Mazumdar, Bob Löwenberg, John M. Greally, Peter J.M. Valk, Ruud Delwel, and Ari Melnick (2010)
Epigenetic Signatures Identify New Clinically Relevant Subtypes in Acute Myeloid Leukemia
Cancer Cell 17(1):13-27